Log In
Print
BCIQ
Print
Print this Print this
 

ErepoXen

  Manage Alerts
Collapse Summary General Information
Company Xenetic Biosciences Inc.
DescriptionLong-acting erythropoietin (EPO)
Molecular Target Erythropoietin (EPO) receptor
Mechanism of ActionErythropoietin (EPO) receptor agonist
Therapeutic ModalityBiologic: Protein
Latest Stage of DevelopmentPhase III
Standard IndicationAnemia
Indication DetailsTreat anemia in chronic kidney disease (CKD) patients; Treat anemia in chronic kidney disease (CKD) patients not requiring dialysis; Treat anemia in chronic renal failure patients on dialysis; Treat anemia in patients receiving renal dialysis
Regulatory Designation

Partner

Serum Institute of India Ltd.; SynBio LLC


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today